Calebin-A induces apoptosis and modulates MAPK family activity in drug resistant human gastric cancer cells.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  European Journal of Pharmacology

• Publication date

  2008-09-04

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.ejphar.2008.06.065PMID 18619958
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Antitumor effects of curcumin and structurally beta-diketone modified analogs on multidrug resistant cancer cells.

  2008cited by this paper
• Curcumin down-regulates the multidrug-resistance mdr1b gene by inhibiting the PI3K/Akt/NF kappa B pathway.

  2008cited by this paper
• Circumvention of the multidrug-resistance protein (MRP-1) by an antitumor drug through specific inhibition of gene transcription in breast tumor cells.

  2007cited by this paper
• Resveratrol-induced cell inhibition of growth and apoptosis in MCF7 human breast cancer cells are associated with modulation of phosphorylated akt and caspase-9

  2006cited by this paper
• Chemopreventive and therapeutic effects of curcumin.

  2005cited by this paper
• Effect of curcumin on multidrug resistance in resistant human gastric carcinoma cell line SGC7901/VCR

  2005cited by this paper
• Reversal of p-glycoprotein-mediated multidrug resistance by CJX1, an amlodipine derivative, in doxorubicin-resistant human myelogenous leukemia (K562/DOX) cells.

  2005cited by this paper
• Inhibition of P-glycoprotein activity and reversal of cancer multidrug resistance by Momordica charantia extract

  2004cited by this paper
• P-glycoprotein expression does not change the apoptotic pathway induced by curcumin in HL-60 cells

  2004cited by this paper
• Some early history of membrane molecular biology.

  2004cited by this paper
• Biochemical mechanism of modulation of human P-glycoprotein (ABCB1) by curcumin I, II, and III purified from Turmeric powder.

  2004cited by this paper
• Expression of multidrug resistance-associated protein1,P-glycoprotein, and thymidylate synthase in gastric cancer patients treated with 5-fluorouracil and doxorubicin-based adjuvant chemotherapy after curative resection

  2002cited by this paper
• Discovery of natural products from Curcuma longa that protect cells from beta-amyloid insult: a drug discovery effort against Alzheimer's disease.

  2002cited by this paper
• Modulation of the atypical multidrug-resistant phenotype by a hammerhead ribozyme directed against the ABC transporter BCRP/MXR/ABCG2

  2002cited by this paper
• Modulation of P-glycoprotein expression and function by curcumin in multidrug-resistant human KB cells.

  2002cited by this paper
• Identification of differentially expressed genes in classical and atypical multidrug-resistant gastric carcinoma cells.

  2002cited by this paper
• MGr1-Ag is associated with multidrug-resistant phenotype of gastric cancer cells

  2002cited by this paper
• Cross-talk between signalling pathways and the multidrug resistant protein MDR-1

  2001cited by this paper
• SB203580, a specific inhibitor of p38-MAPK pathway, is a new reversal agent of P-glycoprotein-mediated multidrug resistance.

  2001cited by this paper
• Biological activities of Curcuma longa L.

  2001cited by this paper
• Role of BAX in the apoptotic response to anticancer agents.

  2000cited by this paper
• Multidrug resistance transporters and modulation

  2000cited by this paper
• Activation of caspase-3 and c-Jun NH2-terminal kinase-1 signaling pathways in tamoxifen-induced apoptosis of human breast cancer cells.

  2000cited by this paper
• Differential sensitivity of human mammary epithelial and breast carcinoma cell lines to curcumin

  1999cited by this paper
• Antimitotic drugs cause increased tumorigenicity of multidrug resistant cells.

  1999cited by this paper
• Curcumin inhibits cell proliferation by interfering with the cell cycle and inducing apoptosis in colon carcinoma cells.

  1999cited by this paper
• Activation of MAP kinases by 5-fluorouracil in a 5-fluorouracil-resistant variant human cell line derived from a KT breast cancer cell line.

  1998cited by this paper
• Inhibition of the c-Jun N-terminal kinase (JNK) signaling pathway by curcumin

  1998cited by this paper
• Glucose Deprivation-induced Cytotoxicity and Alterations in Mitogen-activated Protein Kinase Activation Are Mediated by Oxidative Stress in Multidrug-resistant Human Breast Carcinoma Cells*

  1998cited by this paper
• Induced p53 expression in lung cancer cell line promotes cell senescence and differentially modifies the cytotoxicity of anti-cancer drugs

  1998cited by this paper
• Modulation and prevention of multidrug resistance by inhibitors of P-glycoprotein

  1997cited by this paper
• Role of the Stress-activated/c-Jun NH2-terminal Protein Kinase Pathway in the Cellular Response to Adriamycin and Other Chemotherapeutic Drugs*

  1996cited by this paper
• Glutathione-associated enzymes in anticancer drug resistance.

  1994cited by this paper
• Toxicity studies on Alpinia galanga and Curcuma longa.

  1992cited by this paper
• Expression and activity of P-glycoprotein, a multidrug efflux pump, in human hematopoietic stem cells.

  1991cited by this paper
• The biochemistry of P-glycoprotein-mediated multidrug resistance.

  1989cited by this paper
• Action of calcium antagonists on multidrug resistant cells. Specific cytotoxicity independent of increased cancer drug accumulation.

  1987cited by this paper

• Exploring natural products as apoptosis modulators in cancers: insights into natural product-based therapeutic strategies

  2025cites this paper
• Synergistic effects of Calebin A and docetaxel on apoptosis and migration in prostate cancer cells

  2025cites this paper
• Curcumin Derivatives in Medicinal Chemistry: Potential Applications in Cancer Treatment

  2024cites this paper
• Calebin A attenuated inflammation in RAW264.7 macrophages and adipose tissue to improve hepatic glucose metabolism and hyperglycemia in high-fat diet-fed obese mice.

  2024cites this paper
• Exploring bioactive metabolites produced by endophytes associated with the genus Curcuma L.: A pharmaceutical prospect

  2024cites this paper
• Resveratrol triggers autophagy‐related apoptosis to inhibit the progression of colorectal cancer via inhibition of FOXQ1

  2024cites this paper
• Natural Products for Combating Multidrug Resistance in Cancer.

  2024cites this paper
• Calebin A modulates inflammatory and autophagy signals for the prevention and treatment of osteoarthritis

  2024cites this paper
• Plant Endophytic Fungi: Powerful Catalytic Cells for Biotransformation of Chemical Structures of Biologically Active Compounds

  2024cites this paper
• Navigating Molecular Pathways: An Update on Drugs in Colorectal Cancer Treatment.

  2023cites this paper
• An Overview of the Pharmacological Properties of Calebin-A.

  2023cites this paper
• Calebin A targets the HIF-1α/NF-κB pathway to suppress colorectal cancer cell migration

  2023cites this paper
• The therapeutic potential of curcumin and its related substances in turmeric: From raw material selection to application strategies

  2023cites this paper
• Augmentation of Docetaxel-Induced Cytotoxicity in Human PC-3 Androgen-Independent Prostate Cancer Cells by Combination With Four Natural Apoptosis-Inducing Anticancer Compounds

  2023cites this paper
• A minor metabolite from Curcuma longa effective against metabolic syndrome: results from a randomized, double-blind, placebo-controlled clinical study.

  2023cites this paper
• Curcumin, calebin A and chemosensitization: How are they linked to colorectal cancer?

  2023cites this paper
• Multifunctionality of Calebin A in inflammation, chronic diseases and cancer

  2022influential citation
• Herb and Spices in Colorectal Cancer Prevention and Treatment: A Narrative Review

  2022cites this paper
• Calebin-A prevents HFD-induced obesity in mice by promoting thermogenesis and modulating gut microbiota

  2022cites this paper
• Lesser Investigated Natural Ingredients for the Management of Obesity

  2021cites this paper
• Dipeptidyl peptidase-IV inhibitory action of Calebin A: An in silico and in vitro analysis

  2021cites this paper
• Health benefits of turmeric: Emphasis on anticancer activity

  2021cites this paper
• Effect of Curcumin and Its Derivates on Gastric Cancer: Molecular Mechanisms

  2020cites this paper
• Calebin A Potentiates the Effect of 5-FU and TNF-β (Lymphotoxin α) against Human Colorectal Cancer Cells: Potential Role of NF-κB

  2020cites this paper
• Targeting NF-κB Signaling by Calebin A, a Compound of Turmeric, in Multicellular Tumor Microenvironment: Potential Role of Apoptosis Induction in CRC Cells

  2020cites this paper
• Application of curcumin and its derivatives in tumor multidrug resistance

  2020cites this paper
• Overexpression of P16 reversed the MDR1-mediated DDP resistance in the cervical adenocarcinoma by activating the ERK1/2 signaling pathway

  2019cites this paper
• Non-Curcuminoids from Turmeric and Their Potential in Cancer Therapy and Anticancer Drug Delivery Formulations

  2019cites this paper
• Calebin-A induced death of malignant peripheral nerve sheath tumor cells by activation of histone acetyltransferase.

  2019cites this paper
• Bioconversion of curcumin into calebin-A by the endophytic fungus Ovatospora brasiliensis EPE-10 MTCC 25236 associated with Curcuma caesia

  2019cites this paper
• Biotransformation of Curcumin to Calebin-A: A Pharmacologically Important Novel Curcuminoid from Curcuma Species

  2019cites this paper
• Calebin-A, a Curcuminoid Analog Inhibits α-MSH-Induced Melanogenesis in B16F10 Mouse Melanoma Cells

  2019cites this paper
• Evidence That Calebin A, a Component of Curcuma Longa Suppresses NF-κB Mediated Proliferation, Invasion and Metastasis of Human Colorectal Cancer Induced by TNF-β (Lymphotoxin)

  2019cites this paper
• Glioblastoma Chemoresistance: The Double Play by Microenvironment and Blood-Brain Barrier

  2018cites this paper
• Curcumin-Free Turmeric Exhibits Activity against Human HCT-116 Colon Tumor Xenograft: Comparison with Curcumin and Whole Turmeric

  2017cites this paper
• Preparation of Calebin-A Liposomes and its Antiproliferation in Human Cancer Cells

  2017cites this paper
• An Expeditious, Green and Protecting-Group-Free Synthesis of a Potent Secondary Metabolite Calebin-A and Its Analogues

  2017cites this paper
• Chemical constituents and biological research on plants in the genus Curcuma

  2017cites this paper
• Disposition, Metabolism and Histone Deacetylase and Acetyltransferase Inhibition Activity of Tetrahydrocurcumin and Other Curcuminoids

  2017cites this paper
• Calebin A, a novel component of turmeric, suppresses NF-κB regulated cell survival and inflammatory gene products leading to inhibition of cell growth and chemosensitization.

  2017cites this paper
• Calebin A downregulates osteoclastogenesis through suppression of RANKL signalling.

  2016cites this paper
• Disrupting P-glycoprotein function in clinical settings: what can we learn from the fundamental aspects of this transporter?

  2016cites this paper
• Triptolide exerts pro-apoptotic and cell cycle arrest activity on drug-resistant human lung cancer A549/Taxol cells via modulation of MAPK and PI3K/Akt signaling pathways.

  2016influential citation
• Mammalian drug efflux transporters of the ATP binding cassette (ABC) family in multidrug resistance: A review of the past decade.

  2016cites this paper
• Calebin-A induces cell cycle arrest in human colon cancer cells and xenografts in nude mice

  2016cites this paper
• Role of Phytochemicals in MAPK Signaling Pathway-Mediated Apoptosis: A Possible Strategy in Cancer Chemoprevention

  2016cites this paper
• Calebin-A inhibits adipogenesis and hepatic steatosis in high-fat diet-induced obesity via activation of AMPK signaling.

  2015cites this paper
• Calebin A: Analytical Development for Pharmacokinetics Study, Elucidation of Pharmacological Activities and Content Analysis of Natural Health Products.

  2015cites this paper
• Investigation of repeated dose (90 day) oral toxicity, reproductive/developmental toxicity and mutagenic potential of ‘Calebin A’

  2015cites this paper
• MicroRNA-197 reverses the drug resistance of fluorouracil-induced SGC7901 cells by targeting mitogen-activated protein kinase 1

  2015cites this paper
• MAPK1 of Leishmania donovani Modulates Antimony Susceptibility by Downregulating P-Glycoprotein Efflux Pumps

  2015cites this paper
• Maslinic acid activates mitochondria-dependent apoptotic pathway in cardiac carcinoma.

  2014cites this paper
• EGF reverses multi-drug resistance via the p-ERK pathway in HepG2/ADM and SMMC7721/ADM hepatocellular carcinoma models.

  2014cites this paper
• in HepG2/ADM and SMMC7721/ADM Hepatocellular Carcinoma Models

  2014cites this paper
• Reversing multidrug resistance in hepatocellular carcinoma cells by inhibiting extracellular signal-regulated kinase/mitogen-activated protein kinase signaling pathway activity

  2014cites this paper
• Curcumin-free turmeric exhibits anti-inflammatory and anticancer activities: Identification of novel components of turmeric.

  2013cites this paper
• Involvement of CUL4A in Regulation of Multidrug Resistance to P-gp Substrate Drugs in Breast Cancer Cells

  2013cites this paper
• Signal Transduction Pathways and Transcriptional Mechanisms of ABCB1/Pgp-mediated Multiple Drug Resistance in Human Cancer Cells

  2012cites this paper
• Function of Aurora kinase A in Taxol-resistant breast cancer and its correlation with P-gp.

  2011cites this paper
• JNK1, JNK2, and JNK3 are involved in P-glycoprotein-mediated multidrug resistance of hepatocellular carcinoma cells.

  2010cites this paper
• HZ08, a great regulator to reverse multidrug resistance via cycle arrest and apoptosis sensitization in MCF-7/ADM.

  2010cites this paper
• Down-regulation of extracellular signal-regulated kinase 1/2 activity in P-glycoprotein-mediated multidrug resistant hepatocellular carcinoma cells.

  2009cites this paper